ID | 112928 |
タイトル別表記 | ナローバンドUVBがHeLa細胞とアレルギー性鼻炎モデルラットの鼻粘膜におけるヒスタミンH1受容体遺伝子発現の亢進とアポトーシスの誘導に与える影響
|
著者 |
Okamoto, Kentaro
Tokushima University
Sanada, Nanae
Tokushima University
Yamada, Takuya
Tokushima University
Sugiyama, Manabu
Tokushima University
Michinaga, Shotaro
Osaka Ohtani University
Kitayama, Mika
Tokushima University
|
キーワード | Allergic rhinitis
apoptosis
histamine H1 receptor gene
narrowband-ultraviolet B
phototherapy
|
資料タイプ |
学位論文
|
抄録 | Narrowband-ultraviolet B (NB-UVB) phototherapy is used for the treatment of atopic dermatitis. Previously, we reported that irradiation with 200 mJ/cm2 of 310 nm NB-UVB suppressed phorbol-12- myristate-13-acetate (PMA)-induced up-regulation of histamine H1 receptor (H1R) gene expression without induction of apoptosis in HeLa cells. However, the effect of NB-UVB irradiation on nasal symptoms is still unclear. Here, we show that low dose irradiation with 310 nm NB-UVB alleviates nasal symptoms in toluene 2,4-diisocyanate (TDI)-sensitized allergy model rats. Irradiation with 310 nm NB-UVB suppressed PMA-induced H1R mRNA up-regulation in HeLa cells dose-dependently at doses of 75-200 mJ/cm2 and reversibly at a dose of 150 mJ/cm2 without induction of apoptosis. While, at doses of more than 200 mJ/cm2, irradiation with 310 nm NB-UVB induced apoptosis. Western blot analysis showed that the suppressive effect of NB-UVB irradiation on H1R gene expression was through the inhibition of ERK phosphorylation. In TDI-sensitized rat, intranasal irradiation with 310 nm NB-UVB at an estimated dose of 100 mJ/cm2 once a day for three days suppressed TDI-induced sneezes and upregulation of H1R mRNA in nasal mucosa without induction of apoptosis. These findings suggest that repeated intranasal irradiation with low dose of NB-UVB could be clinically used as phototherapy of AR.
|
掲載誌名 |
Journal of Pharmacological Sciences
|
ISSN | 13478613
|
cat書誌ID | AA12022662
|
出版者 | Elsevier|Japanese Pharmacological Society
|
巻 | 138
|
号 | 1
|
開始ページ | 54
|
終了ページ | 62
|
発行日 | 2018-09-10
|
備考 | 内容要旨・審査要旨・論文本文の公開
本論文は, 著者Tatsuya Fujiiの学位論文として提出され, 学位審査・授与の対象となっている。 |
権利情報 | © 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
博士論文全文を含む
|
文科省報告番号 | 甲第3246号
|
学位記番号 | 甲医第1395号
|
学位授与年月日 | 2018-11-22
|
学位名 |
博士(医学)
|
学位授与機関 |
徳島大学
|
部局 |
病院
医学系
薬学系
|